Nantes, France, March 16, 2026 – 7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced its financial calendar for 2026. InformationDate* 2025 Full-Year Financial ...
Nantes, France, March 23, 2026 - 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results